351 related articles for article (PubMed ID: 25001132)
1. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
[TBL] [Abstract][Full Text] [Related]
2. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
Lee KB; Kim UK
Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
[TBL] [Abstract][Full Text] [Related]
3. [Progression of autosomic dominant polycystic kidney disease. Influence of endothelial NO synthase (ecNOS) and renin angiotensin system gene polymorphisms].
Azurmendi P; Fraga A; Muchnik C; Dos Ramos Farias M; Galan F; Guerra D; O'Flaherty M; Arrizurieta E; Martin R
Medicina (B Aires); 2004; 64(2):139-42. PubMed ID: 15628301
[TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensin converting enzyme (
Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
[TBL] [Abstract][Full Text] [Related]
5. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Cassis L
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
[TBL] [Abstract][Full Text] [Related]
6. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Lee KB; Kim UK; Lee CC
J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
8. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease.
Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy.
Huang HD; Lin FJ; Li XJ; Wang LR; Jiang GR
Chin Med J (Engl); 2010 Nov; 123(22):3238-42. PubMed ID: 21163122
[TBL] [Abstract][Full Text] [Related]
11. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular risk in polycystic kidney disease].
Di Lorenzo A; Stallone G; Infante B; Grandaliano G; Schena FP
G Ital Cardiol (Rome); 2015 Sep; 16(9):479-84. PubMed ID: 26418387
[TBL] [Abstract][Full Text] [Related]
13. Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function--a single-center experience.
Siekierka-Harreis M; Kuhr N; Willers R; Ivens K; Grabensee B; Mondry A; Loh MC; Rump LC; Blume C
Clin Transplant; 2009; 23(5):606-15. PubMed ID: 19681973
[TBL] [Abstract][Full Text] [Related]
14. Familial Analysis of Epistatic and Sex-Dependent Association of Genes of the Renin-Angiotensin-Aldosterone System and Blood Pressure.
Scurrah KJ; Lamantia A; Ellis JA; Harrap SB
Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28506960
[TBL] [Abstract][Full Text] [Related]
15. Urinary renin-angiotensin markers in polycystic kidney disease.
Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: interplay with hypertension and intakes of sodium, potassium and fluid.
Deckers IA; van den Brandt PA; van Engeland M; van Schooten FJ; Godschalk RW; Keszei AP; Schouten LJ
Int J Cancer; 2015 Mar; 136(5):1104-16. PubMed ID: 24978482
[TBL] [Abstract][Full Text] [Related]
17. Angiotensinogen gene polymorphisms and progression of chronic kidney disease in ADPKD patients.
Gnanasambandan R; Elumalai R; Soundararajan P; Lakkakula BVKS
Clin Exp Nephrol; 2016 Aug; 20(4):561-568. PubMed ID: 26482465
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone synthase gene is not a major susceptibility gene for progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula BVKS
Saudi J Kidney Dis Transpl; 2017; 28(3):552-557. PubMed ID: 28540892
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of renin-angiotensin system and nitric oxide synthase genes polymorphisms in pre-eclampsia.
Benedetto C; Marozio L; Ciccone G; Chieppa G; Quaglia M; Matullo G; Bertola L; Guarrera S; Carturan S; Stratta P
Acta Obstet Gynecol Scand; 2007; 86(6):678-82. PubMed ID: 17520398
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction.
Ayed Kh; Ayed-Jendoubi S; Ben Abdallah T; Bardi R; Gorgi Y; Sfar I; Dhrif B; Abderrahim E; Kheder A
Transpl Immunol; 2006 Apr; 15(4):303-9. PubMed ID: 16635753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
